Évaluation de la qualité de vie chez les femmes traitées pour endométriose profonde : stratégie médicale versus stratégie chirurgicale

In: Médecine humaine et pathologie. 2018 · 2018 · W2909349687
article OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex
⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-28 · read from full text ⓘ

The provided text does not contain the body of a research paper but rather a security challenge page generated by a bot protection system called Anubis. It explains that the site uses a Proof-of-Work scheme to deter automated scraping and requests users to disable certain browser plugins like JShelter to proceed. Consequently, no data regarding quality of life, endometriosis treatment strategies, or patient outcomes is available for summary. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Introduction: endometriosis is a disease that directly affects women’s daily life. Assessing the impact of this disease and the treatments on their quality of life is essential in the choice of therapeutic strategy. At the moment, there is no consensus on the preferred therapeutic method. The main objective of our study is to define whether the first-line medical strategy is as effective as the surgical strategy in terms of quality of life. Method: in this observational study, 101 women with deep endometriosis were included: 52 received first-line medical treatment (M1) and 49 received first-line surgery (C1). Patients answered a questionnaire that included several validated scores : Endometriosis Health Profile-5 (EHP-5), Knowles-Eccersley-Scott Symptom score (KESS), Female Sexual Function Index (FSFI), and overall life (EAN). The primary outcome was the results on quality of life scores. The impact of digestive disorders and the effect of time on therapeutic efficacy were also evaluated. Prognostic factors in the response to treatment were assessed. Results: women who benefit from first-line surgery had significantly better quality of life scores for EHP-5, KESS and FSFI (respectively p = 0.032, p = 0.035, p = 0.049). There was no difference on the EAN (p = 0.4). Without gastrointestinal lesion, there was no significant difference on the scores between therapeutic strategies. Patients with gastrointestinal lesion who benefit from surgery had significantly better EHP-5 and KESS scores (p = 0.02 and p = 0.038). There was no difference on the FSFI (p = 0.113) and the EAN (p = 0.342). Patients treated by surgery for more than 36 months had a better quality of life. No correlation was found between the age of the patients and their response to treatment. The primiparous or multiparous patients had better quality of life scores. Conclusion: we found no difference in terms of quality of life between therapeutic strategies for patients with deep endometriosis without digestive localisation. On the other hand, women with digestive endometriosis receiving a surgical treatment have a better quality of life. Randomized comparative studies are needed to determine the best therapeutic approach in the treatment of digestive endometriosis.
Full text 1,068 characters · extracted from oa-html · click to expand
Making sure you're not a bot! Loading... You are seeing this because the administrator of this website has set up Anubis to protect the server against the scourge of AI companies aggressively scraping websites. This can and does cause downtime for the websites, which makes their resources inaccessible for everyone. Anubis is a compromise. Anubis uses a Proof-of-Work scheme in the vein of Hashcash, a proposed proof-of-work scheme for reducing email spam. The idea is that at individual scales the additional load is ignorable, but at mass scraper levels it adds up and makes scraping much more expensive. Ultimately, this is a placeholder solution so that more time can be spent on fingerprinting and identifying headless browsers (EG: via how they do font rendering) so that the challenge proof of work page doesn't need to be presented to users that are much more likely to be legitimate. Please note that Anubis requires the use of modern JavaScript features that plugins like JShelter will disable. Please disable JShelter or other such plugins for this domain.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Outcome instruments

EHP-30

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK